No photo available

Distinguished Professor Vicky Avery


  • Bio/Profile

    Distinguished Professor Avery is the Director, Centre for Cellular Phenomics; Principal Research Leader, Griffith Institute for Drug Discovery; Head of Griffith’s Drug Discovery Programme for Cancer Therapeutics and Research Member, Infectious Diseases & Immunity, Menzies Health Institute Queensland, Griffith University.

    She is a world recognized and respected leader in drug discovery, with considerable experience in high content imaging and high throughput screening. She established world class facilities and amongst her contributions, pioneered image-based drug discovery for parasitic diseases.

    Since returning to academia in 2007, she has contributed to 7 clinical candidates for malaria, receiving awards of Malaria Drug Discovery Project of the Year 2007 and 2013; and to DNDI-6174 for visceral leishmaniasis, in preclinical development for Phase I trials.


    Thinking together – Acting together Thinking Thinking together – Acting together – Acting together

    Prof Avery was a founding member of the CRC for Cancer Therapeutics (2007-20), contributing to pre-clinical development of drug candidates, resulting in successful commercialisation with Merck ($730M-2016) and Pfizer ($650M-2018).

    Since 2007, Prof Avery has been a co-investigator on grants valued in total ~$121 million, and contributor to commercial deals with upfront payments >$40 million. In the last 5 years she has been CIA on >$15 million and has considerable commercial in confidence funding.

    Throughout her career, she has made significant contributions to the development of innovative techniques and new candidate drugs, improving treatment options for numerous disease indications.